Tags:Human
Nurix is focused on discovering and developing therapies that modulate the ubiquitin proteasome system (UPS) for the treatment of a broad range of human disorders, most notably cancer.
Total raised: $145.1M

Investors 1

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
12.03.2020-$120M--
22.05.2014Series B$25.1M--

Mentions in press and media 3

DateTitleDescriptionCategoryAuthorSource
13.03.2020After Kyme...Sanofi- and Gilead Sciences-ba...Biotech-fiercebiot...
22.05.2014Nurix Rais...Nurix, Inc., a San Francisco, ...funding S...-finsmes.co...
04.04.2013Stealthy b...Formed in 2009 as Kura Therape...--medcitynew...